Clicky

Guangzhou Wondfo Biotech Co Ltd(300482)

Description: Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.


Keywords: Medicine Disease Diabetes Tumor Inflammation Cardiovascular Disease Chronic Disease Thyroid Chronic Condition Point Of Care Testing Blood Gas Sexually Transmitted Diseases Kidney Injury

Home Page: www.wondfo.com.cn

No.8 Lizhishan Road
Guangzhou,
China
Phone: 86 40 0830 8768


Officers

Name Title
Mr. Wen Mei Li MD & Director
Ms. Fang Xia Yu CFO & Deputy GM
Ms. Ke Ren Kang Deputy Gen. Mang.
Mr. Zhongxiong Peng Deputy GM & Director
Yaping Zhao Deputy Gen. Mang.
Ms. Tong Zhang Deputy Gen. Mang.
Ms. Hong Hu Board Sec.
Mr. Hong Luo Deputy Gen. Mang. and Director

Exchange: SHE

Country: CN : China

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 11.0957
Price-to-Book MRQ: 4.8448
Price-to-Sales TTM: 3.4622
IPO Date:
Fiscal Year End: December
Full Time Employees: 3411
Back to stocks